Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

What Excites You Most About the Life Sciences Industry in 2021?

Posted on February 19th, 2021 by in Pharma R&D

We have looked back at some of the biggest advances in 2020, but it’s a new year and time to look ahead, so we asked our Life Sciences team what they are looking forward to in 2021.

(more…)

What Were the Biggest Advances in Life Sciences in 2020?

Posted on February 8th, 2021 by in Pharma R&D

As we settle into a new year, it’s always good to take a moment to consider what was accomplished in the previous one. That’s why we asked members of Elsevier’s Life Sciences team what they felt were among the most noteworthy advances in the life sciences in 2020.

(more…)

Looking at Emerging Trends in Telemedicine

Posted on December 17th, 2020 by in Pharma R&D

Telemedicine, once an intriguing proposition struggling to reach its potential, became an absolute necessity in 2020. In the early days of COVID-19, as medical centers labored to deal with an influx of patients while also trying to mitigate coronavirus spread, telemedicine was urgently needed as an option for providing healthcare to others at a safe distance. In the U.S., the government and providers quickly started to take measures to facilitate its use during the crisis of the pandemic.

(more…)

New Coronavirus Advisory Team Announced

Posted on November 16th, 2020 by in COVID-19

Wasting no time to start enacting his forthcoming administration’s plan for tackling COVID-19, new president-elect of the United States, Joe Biden, has unveiled his coronavirus advisory team. “Dealing with the coronavirus pandemic is one of the most important battles our administration will face, and I will be informed by science and by experts,” he stated.

(more…)

  1. 1
  2. 2
  3. 3
  4. …
  5. 6